MediciNova Announces Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model to be Presented at The Liver Meeting Digital Experience™ 2020

NEXT STORY
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2020
PREV STORY
Randomized Controlled Phase 3 Trial of Remestemcel-L for Reduced Mortality in COVID-19 Acute Respiratory Distress Syndrome Surpasses 50% Enrollment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ACR 2019: Lilly Presents Positive New Data from COAST-X, a Phase 3 Study of TALTZ® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis

author_avatar
NASDAQ Market News

Adverum Biotechnologies Appoints Katherine Bock as Vice President, Investor Relations & Corporate Communications

MENLO PARK, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a ...

author_avatar
NASDAQ Market News

Alimera Sciences Announces Top Line Revenue Expectation For the Third Quarter of 2019

author_avatar
NASDAQ Market News